vessel walls, sometimes in what appear to be alveolar spaces. Bronchoscopy showed a dry and shiny mucosa with only a few submucous glands in the bronchial biopsy sections. Serology: DAT 1/16, latex + +. Lung antibodies present at low titre (Dr M Turner-Warwick). Antinuclear factor, LE cells and thyroid antibodies absent. Progress: Prednisolone treatment caused considerable regression of parotid enlargement but no change in the dryness of the eyes or mouth. There were no more rales at the bases and X-rays showed moderate clearing in both lower zones. Pulmonary function tests showed improvement in diffusing capacity and compliance with Po2 and arterial oxygen saturation back to near normal.
Comment
There are few histological reports of lung lesions in Sjogren's syndrome. We found only 3 autopsy cases (Ellman et al. 1951 , Cardell & Gurling 1954 , Bucher & Reid 1959 and 2 lung biopsies (Bates & Christie 1964 , Bloch et al. 1965 1) . No sacral aedema. A few small fixed lymph nodes in both groins. Investigations: Hb 16.4 g/100 ml. WBC 5,000-11,000; differential white cell counts showed intermittent lymphopenia: 4 out of 8 counts <1,000 (mean 1,100, range 600-1,800). No microfilaria seen in blood film. Filarial complement fixation test and skin tests negative.
Total serum proteins 4-9, albumin 2-9, globulin 2-0 g/100 ml. Immunoglobulins: yG 170 (normal 600-1,600) mg/100 ml; yA 175 (normal 150-450) mg/100 ml; yM 20 (normal 50-150) mg/100 ml. No Barium meal and follow-through: slight dilatation of the small bowel and coarse mucosal folds. Jejunal biopsy (Fig 2) : some dilated submucosal lymphatics. Fmecal fat 4-11 g/day (normal <6 g/day). Absorption of vitamin E using tritiated a-tocopherol, net absorption 30 % (normal >55 %). Peak of plasma radioactivity (Fig 3) diminished and delayed.
Lymphangiogram of right lower limb: at 24 hours the radiopaque oil had not passed the level of L2, and had crossed over to the left side, suggestive of a block at this level.
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--~~~~~~~~~~~~~~~~~~~. . . . . . The hypoproteinemia in this patient is clearly due to protein-losing enteropathy, probably secondary to acquired intestinal lymphangiectasia, the cause of which is not certain. The history and physicial signs are very suggestive of filariasis. The absence of microfilaria in the blood does not exclude the diagnosis, since the initial infection was probably seventeen years previously. The negative skin test and complement fixation test also do not rule it out. The skin test was positive in only 32 out of 46 proven cases of Bancroftian filariasis reported by Ridley & Stott (1961) , and the CFT was positive in only 21. Steatorrhoea has been described in filariasis (Gad El-Mawla et al. 1966) , and chylous diarrheea is a well recognized but rare complication; however, hypoproteinTmia secondary to proteinlosing enteropathy has not been recorded. Waldmann (1966) lists 35 causes of proteinlosing enteropathy, but does not include filariasis. He postulates that in some diseases, such as congenital lymphangiectasia and Whipple's disease, lymph rather than plasma is lost into the gut, and this leads to a low lymphocyte count. The intermittent lymphopenia in this man suggests that he is also losing lymph into the gut.
The patient had only mild steatorrhoea but severe malabsorption of vitamin E. This suggests that an intact lymphatic system is more important for the absorption of vitamin E than for the absorption of dietary fat. Kayden & Medick (1969) have shown that rats can absorb long chain triglycerides even when the formation of chylomicrons is inhibited with puromycin. Similar studies on the absorption of fat soluble vitamins would be of interest.
Sir Robert Drew said that the possibility of filariasis as the cause must certainly be entertaincd. However, further evidence would be needed before a definite diagnosis could be made. He asked whether eosinophilia was present at any stage and suggested that the skin test for filariasis be repeated. He wondered whether biopsy of a gland would be possible and if the blood had been examined for microfilari. both by day and by night. He suggested that a trial with diethylcarbamazine be continued to see if the symptoms remitted.
